Predictive oncology to report second quarter 2023 financial results and host conference call and webcast on thursday, august 10, 2023

Eagan, minn., aug. 03, 2023 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, clinical laboratory improvement amendments (clia) laboratory and good manufacturing practices (gmp) facility, to accelerate oncology drug discovery and enable drug development, today announced that it will report its financial results for the second quarter ended june 30, 2023 after the markets close on thursday, august 10, 2023.
POAI Ratings Summary
POAI Quant Ranking